Hypersensitivity reactions to fillers may occur after COVID-19 vaccination People may experience hypersensitivity reactions to fillers following a COVID-19 vaccination.
High rates of RSV in children over the summer, and a late flu epidemic in the 2021-2022 season Hospitals reported an unusually large number of children presenting with RSV over the summer of 2021. The number of positive coronavirus tests rapidly increased after the summer of 2021.
Satellite data on emissions may be even more precise and user-friendly Satellites are continuously improving and provide more precise measurements. They are used, for example, for studying emissions of greenhouse gases and other air pollutants.
Repeat vaccination against COVID-19: risk groups first, then everyone 12 and up The first invitations for a repeat vaccination against COVID-19 will be received by people in the Netherlands on 13 September 2022. RIVM will invite the oldest people first, and will then send an invitation to everyone aged 60 years and older.
Nearly one quarter of the Dutch population suffers from stomach, liver and/or bowel problems In 2019, nearly one in four people in the Netherlands had visited their general practitioner for stomach, liver and/or bowel problems of a more or less serious nature.
Use of Salvia divinorum may have adverse health effects The use of Salvia divinorum may have adverse health effects. Among other things, it may lead to hallucinations, restlessness, confusion, elevated heart rate and blood pressure, and psychosis.
Almost half of 9 and 10-year-olds get HPV vaccination at first opportunity This spring, more than 800,000 young people received an invitation to be vaccinated against HPV, the human papillomavirus.
Less air pollution from traffic and industry but increased contribution from agriculture International air policy has shown good results in Europe: in the past 35 years the air has become cleaner. Nevertheless air pollution is still an important cause of premature death.
Early detection of work-related health risks in Europe At European level, different methods are used to identify substances and processes that may cause cancer as early as possible, the so-called early warning systems.
Burden of disease and societal costs of work-related cancer in the European Union Yearly approximately 122,600 people in the EU are diagnosed with cancer, caused by past exposure to carcinogenic substances at work.